Home » Topics » BioWorld Science

BioWorld Science
RSS

Novel selective c-Abl inhibitor prevents neurodegeneration in models of Parkinson's

Dec. 3, 2021

BCL10/MALT1 axis found to be involved in psoriasis

Dec. 3, 2021

Orion completes OB-004 lead optimization

Dec. 3, 2021

GAT-564, a novel CB1R allosteric modulator with efficacy in murine model of glaucoma

Dec. 3, 2021

J2H Biotech synthesizes new compounds for liver cancer

Dec. 3, 2021

Bristol Myers Squibb synthesizes new galectin-3 inhibitors

Dec. 3, 2021

PMV Pharmaceuticals identifies new TP53 mutant stabilizers

Dec. 3, 2021

Merck & Co. divulges coagulation factor XIa inhibitors

Dec. 3, 2021

Accutar Biotechnology patents EGFR and/or HER2 inhibitors

Dec. 3, 2021

HCN targeting rescues chronic stress-induced cognitive deficits

Dec. 3, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...